• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Office of Minority Health Infrastructure Development

Description: Identify resources to implement FDA's minority health mission and vision.

Accomplishment: FDA staff has completed this infrastructure development project which put in place the components necessary to establish an FDA Office of Minority Health. These infrastructure components include: identifying available office space, creating a budget for OMH, identifying an FDA representative to serve on the HHS Health Disparities Council, and other activities. Putting this infrastructure into place will facilitate FDA’s efforts to carry out the minority health directives in the Affordable Care Act.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Identify an Acting Director for new office

10/31/2010

Completed 11/1/2010

B. Identify FDA/OMH minority health representative for HHS Health Disparities Council and regularly attend council meetings

10/31/2010

Completed 12/31/2010

C. Generate awareness of new office with stakeholder groups

11/13/2010

Completed 12/31/2010

D. Identify and allocate space for new office

11/30/2010

Completed 12/31/2010

E. Create an Office of Minority Health web page

11/30/2010

Completed 12/31/2010

F. Create itemized budget for the new Office of Minority Health

12/31/2010

Completed 12/31/2010

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.